Nuclera, the biotechnology company accelerating drug discovery by providing rapid, easy access to functional proteins through ...

[Introduction] Recently, the prognosis of B-cell acute lymphoblastic leukemia (B-ALL) has significantly improved with the appearance of novel drugs, including inotuzumab ozogamicin (IO) and ponatinib.

Planar waveguide (PWG) technology (right) has the advantage over conventional epifluorescence excitation (left) for surface-confined assays in that only surface-bound fluorphores respond to the ...

Expression proteomics determines where and when proteins are expressed and measures their quantities. This qualitative and quantitative approach can compare protein expression across conditions, such ...

REDDING, Calif., Oct. 01, 2024 /PRNewswire/ -- According to a new market research report titled, 'China Neurogenomics Market Size, Share, Forecast, & Trends Analysis ...

According to Precedence Research, the global microarray market size was estimated at USD 5.46 billion in 2023 and is projected to reach USD 13.81 billion by 2034, registering a CAGR of 8.8% from 2024 ...

A single genetic test could potentially replace the current two-step approach to diagnosing rare developmental disorders in children. This shift could enable earlier diagnoses for families and save ...

Abstract: The paper proposes and demonstrates a novel protein microarray chip with an embedded microchannel array for the delivery of protein separately. This chip system is applicable to high ...